Specific mutations of hepatitis B virus in plasma predict liver cancer development.
about
Mycotoxins and human disease: a largely ignored global health issueHBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers.Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaCirculating tumor DNA in hepatocellular carcinoma: trends and challengesHepatocellular carcinoma and hepatitis B surface proteinDNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapyMutation profiling of the hepatitis B virus strains circulating in North Indian populationRainbow trout (Oncorhynchus mykiss) and ultra-low dose cancer studiesHepatitis B virus subgenotypes and basal core promoter mutations in Indonesia.The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma.Viral hepatitis and hepatocellular carcinoma: etiology and managementHepatitis B virus-induced oncogenesis.Pathogenesis of hepatitis B virus infectionDetection of hepatitis B virus genotypes using oligonucleotide chip among hepatitis B virus carriers in Eastern China.A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma.Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinomaUpdate on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus InfectionPredictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from ThailandMass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluidsHepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity.Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.Hepatitis B virus infection and the risk of hepatocellular carcinoma.DNA markers in molecular diagnostics for hepatocellular carcinoma.Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection.NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in miceThe molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma.Hepatitis B virus genetic variants: biological properties and clinical implicationsOverview of hepatitis B viral replication and genetic variabilityHBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.An overview of molecular epidemiology of hepatitis B virus (HBV) in IndiaProspective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, ChinaStronger enhancer II/core promoter activities of hepatitis B virus isolates of B2 subgenotype than those of C2 subgenotype.Role of viral factors in the natural course and therapy of chronic hepatitis B.Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes.
P2860
Q24650056-D639E41E-71CA-42F0-98B8-D1207E036096Q24811785-8A588A7B-3011-4540-AE96-55A3995A9EAFQ26743361-CAAEBAF7-D587-4309-8359-465B3B537B1BQ26749417-530FE7E5-CF14-4D44-8A35-AC583FE34485Q26766123-A7EAC634-21D9-48A4-8AFD-53A64B3C695EQ27336155-268864F6-F837-4A0D-951C-1DF2AF04C9A2Q28075923-D7BDB6B5-2EDB-488F-BBBF-FE180EE9DEECQ28540948-7BF27292-71DA-4999-BD0A-BA66320B56BAQ28750637-44A0C562-8D5A-4782-BB0F-F38E38D3EF32Q30872732-C7F56F77-EDB6-41F1-BE3E-7668F1E67FE5Q30944734-ACA89F37-B37C-48ED-BBE1-7FBC0FE887F0Q33553814-0931E5A0-963E-48C5-AD21-E3CFDB351E81Q33593219-7E7856E8-FFA4-4BC5-A3B9-B8D45D6AFEBFQ33787553-651E31B2-20D4-44EA-93EF-282EF582AB29Q33925491-857C90CB-5E20-4299-A028-F37F637C8691Q34099470-E8BC43D4-D6D7-4890-9A1A-46466BA26C65Q34130365-FE688F94-4975-485B-8C0D-B4F2108DC7DEQ34514581-5F1CEEEE-7ECA-467E-9A2F-9256D1D94CD7Q34892826-4C87864C-596F-4D61-A1C3-697F7EFED2FCQ35020474-95E55B9D-5211-4FE1-B808-12B5AFEEEE0BQ35094277-C16A8A5A-605C-4BE0-BF14-74BF262A87ADQ35099257-4F0D78DB-FA30-4CD1-AE64-0247F1583CD1Q35269350-53FE3C7C-8AC5-4925-A01F-37C1E0762CBDQ35382430-1B324FFF-21B8-444F-A273-E8CC9A857CF5Q35579913-D749BBDB-3A7C-4195-B7B1-3D58B62E818AQ35606904-3ADEF830-B0A9-46B8-89E0-78B5B854C304Q35781255-785EF38D-71C5-43EA-BBEC-56DD8836165BQ36098721-EA45D28F-23EF-4BE5-8973-115C1CEFA861Q36227142-50DB1949-1590-4B2A-B46A-433195293E04Q36307099-98657AA3-6B13-4C16-9FC7-D951D40A31D7Q36333330-C4EFF42E-3112-4849-A001-52B97633629EQ36419017-1C8C6186-1778-430A-A5CA-9F098E01B161Q36795324-7F59587C-C06D-49E3-99CB-BBC64D162716Q36807341-82229BC7-F08F-45B8-A607-FC524B260CFEQ36935260-E2A21ABB-38B5-4994-9CEE-7A27CD0CDADDQ37092920-E8D6745C-06AC-4C30-BC5E-84D54953AE36Q37093046-69061D6E-3116-4059-8023-7ADB21E46D33Q37128311-CC52C6D9-9340-4585-B615-42A78E82E5A9Q37280144-F21C21EF-1E7A-4D79-94E6-396F3946B3D8Q37312846-8FE4870A-0938-4C3D-A976-9978F7293E3B
P2860
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
@en
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
@nl
type
label
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
@en
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
@nl
prefLabel
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
@en
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
@nl
P2093
P2860
P356
P1476
Specific mutations of hepatitis B virus in plasma predict liver cancer development.
@en
P2093
Alvaro Muñoz
Geng-Sun Qian
Jin-Bing Wang
John D Groopman
Pei-Xing Lu
Peta E Jackson
Shuang-Yuan Kuang
Thomas W Kensler
P2860
P304
P356
10.1073/PNAS.0308232100
P407
P577
2004-02-27T00:00:00Z